Creatine Supplementation (3 g/d) and Bone Health in Older Women: A 2-Year, Randomized, Placebo-Controlled Trial
- PMID: 31257405
- DOI: 10.1093/gerona/glz162
Creatine Supplementation (3 g/d) and Bone Health in Older Women: A 2-Year, Randomized, Placebo-Controlled Trial
Abstract
Background: Creatine supplementation could be a nonexpensive, safe, and effective dietary intervention to counteract bone loss. The aim of this study was to investigate whether long-term creatine supplementation can improve bone health in older, postmenopausal women.
Methods: A double-blind, placebo-controlled, parallel-group, randomized trial was conducted between November 2011 and December 2017 in Sao Paulo, Brazil. Two hundred postmenopausal women with osteopenia were randomly allocated to receive either creatine monohydrate (3 g/d) or placebo for 2 years. At baseline and after 12 and 24 months, we assessed areal bone mineral density (aBMD; primary outcome), lean and fat mass (through dual X-ray absorptiometry), volumetric BMD and bone microarchitecture parameters, biochemical bone markers, physical function and strength, and the number of falls and fractures. Possible adverse effects were self-reported.
Results: Lumbar spine (p < .001), femoral neck (p < .001), and total femur aBMD (p = .032) decreased across time; however, no interaction effect was observed (all p > .050). Bone markers, microarchitecture parameters, and the number of falls/fractures were not changed with creatine (all p > .050). Lean mass and appendicular skeletal muscle mass increased throughout the intervention (p < .001), with no additive effect of creatine (p = .731 and p = .397, respectively). Creatine did not affect health-related laboratory parameters.
Conclusion: Creatine supplementation more than 2 years did not improve bone health in older, postmenopausal women with osteopenia, nor did it affect lean mass or muscle function in this population. This refutes the long-lasting notion that this dietary supplement alone has osteogenic or anabolic properties in the long run.
Clinical trial registry: Clinicaltrials.gov: NCT: 01472393.
Trial registration: ClinicalTrials.gov NCT01472393.
Keywords: Bone mass; Creatine; Muscle function; Nutrition; Postmenopausal.
© The Author(s) 2019. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Effects of long-term low-dose dietary creatine supplementation in older women.Exp Gerontol. 2015 Oct;70:97-104. doi: 10.1016/j.exger.2015.07.012. Epub 2015 Jul 17. Exp Gerontol. 2015. PMID: 26192975 Clinical Trial.
-
The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial.Osteoporos Int. 2021 Jan;32(1):185-191. doi: 10.1007/s00198-020-05638-z. Epub 2020 Oct 8. Osteoporos Int. 2021. PMID: 33030563 Clinical Trial.
-
Creatine supplementation and resistance training in vulnerable older women: a randomized double-blind placebo-controlled clinical trial.Exp Gerontol. 2014 May;53:7-15. doi: 10.1016/j.exger.2014.02.003. Epub 2014 Feb 13. Exp Gerontol. 2014. PMID: 24530883 Clinical Trial.
-
Potential of creatine supplementation for improving aging bone health.J Nutr Health Aging. 2010 Feb;14(2):149-53. doi: 10.1007/s12603-009-0224-5. J Nutr Health Aging. 2010. PMID: 20126964 Review.
-
The Role of Prunes in Modulating Inflammatory Pathways to Improve Bone Health in Postmenopausal Women.Adv Nutr. 2022 Oct 2;13(5):1476-1492. doi: 10.1093/advances/nmab162. Adv Nutr. 2022. PMID: 34978320 Free PMC article. Review.
Cited by
-
The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper.Arch Med Sci. 2023 Jun 9;19(4):841-864. doi: 10.5114/aoms/167799. eCollection 2023. Arch Med Sci. 2023. PMID: 37560745 Free PMC article.
-
Is It Time for a Requiem for Creatine Supplementation-Induced Kidney Failure? A Narrative Review.Nutrients. 2023 Mar 18;15(6):1466. doi: 10.3390/nu15061466. Nutrients. 2023. PMID: 36986197 Free PMC article. Review.
-
Response to Letter to the Editor, "Sarcopenic Obesity: An Emerging Public Health Problem, But an Answer Appears to Be Available".Aging Dis. 2022 Jun 1;13(3):637-638. doi: 10.14336/AD.2021.1120-1. eCollection 2022 Jun. Aging Dis. 2022. PMID: 35656111 Free PMC article. No abstract available.
-
Anti-Inflammatory and Anti-Catabolic Effects of Creatine Supplementation: A Brief Review.Nutrients. 2022 Jan 27;14(3):544. doi: 10.3390/nu14030544. Nutrients. 2022. PMID: 35276903 Free PMC article. Review.
-
Creatine Supplementation in Women's Health: A Lifespan Perspective.Nutrients. 2021 Mar 8;13(3):877. doi: 10.3390/nu13030877. Nutrients. 2021. PMID: 33800439 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical